Skip to main content
. 2019 May 20;20(10):2480. doi: 10.3390/ijms20102480

Figure 5.

Figure 5

All YIL781-treated mice experience Phase IV seizures. (A) Correlation between number of Phase III and IV seizures visually observed and number of hippocampal discharges on EEG (controls and YIL781-treated mice taken together; n = 9 pairs). Pearson correlation (p < 0.01; Pearson’s r = 0.8113). (B) One-hundred percent of YIL781-treated mice (n = 6) experienced Phase IV seizures while 17% of saline-treated controls (n = 6) did. Fisher’s exact test (p < 0.05). * p < 0.05; EEG, electro-encephalography.